National Boston Medical, Inc. Sees Growing Momentum For Bontempi Instrument Sales With the Alliance of Dr. Anthony Mirarchi and Mr. Victor Bianchi
PR Newswire - September 16, 1999 12:22
TAUNTON, Mass., Sept. 16 /PRNewswire/ -- NATIONAL BOSTON MEDICAL, Inc. (OTC Bulletin Board: NBMX) announced today a new innovative management structure to lead its U.S. marketing activities of the sales of Bontempi Dental, Medical and Veterinary Instruments. Dr. Anthony Mirarchi will be assuming sales and marketing leadership effective immediately in collaboration with Mr. Victor Bianchi, President of Bontempi Medical Corporation.
Dr. Anthony Mirarchi, B.Sc., D.D.S. is an alumnus of McGill University where he was awarded a Bachelor of Science in 1984 and concluded his Doctor of Dental Surgery in 1988. Upon graduation, he won a teaching position and at the same time he began his own private practice. Today, Dr. Mirarchi owns and manages a highly successful multi-office dental practice and also manages the residency program at McGill University, where he has instituted a creative method to integrate McGill's recently graduated Dentists into the private sector. He holds an appointment from the Board of Directors of the McGill University Health Center as an Assistant Professor of the Faculty of Dentistry, and he is a member of the Academy of General Dentistry. Dr. Mirarchi is a highly regarded medical, education and business professional. National Boston Medical Inc. has recruited Dr. Mirarchi for his proven entrepreneurship, organizational and management skills and leadership ability.
Mr. Daniel Hoyng, President and CEO of National Boston Medical, Inc. said, "By strengthening the management for sales and marketing in our largest market, we will drive sustained growth and profitability of the Company. Dr. Anthony Mirarchi's experience and professional contacts throughout the dental industry will provide an excellent springboard by becoming Bontempi's Marketing Director, while Victor Bianchi brings a wide range of strategic sales and marketing experience to the Company. Jointly, they will play a crucial role in expanding sales opportunities for National Boston Medical, Inc." Mr. Bianchi has more than 20 years of business and management experience and currently serves as a Director and Board Member of National Boston Medical, Inc.
Mr. Daniel Hoyng goes on to say, "The addition of Dr. Anthony Mirarchi to the marketing efforts of the Bontempi Division of National Boston Medical adds the final important dimension because of his professional and academic connections to dental colleges. These connections will be invaluable to penetrating the multi-billion dollar market of Dental, Medical and Veterinary Instruments.
Dr. Mirarchi affirmed, "I am very pleased with recent developments in Bontempi. Under the leadership of Mr. Victor Bianchi, Bontempi Medical Instruments, Canada has captured 10% of the Canadian dental market in less than two years. NBM is an exciting new company with a compelling business strategy for the Dental, Medical and Veterinary instruments, and we hope to capture at least 10% of the U.S. market over the next two years. The Bontempi products of quality surgical instruments are well positioned to become the U.S. standard within this large and rapidly developing market sector."
National Boston Medical, Inc. presently operates as two divisions. The Bontempi Instrument Division, which features medical, dental and veterinary instruments that are sold through distributors throughout the United States; and Flex Marketing Division, which focuses on marketing products through direct response advertising to retail distribution. Flex Marketing is presently promoting the highly successful Backstroke(R) Back Massager, Cactus Jack's One-Shot(R) product line and Designs by Dean(R).
For investor information, contact Global Development Advisors at 561-694- 9425 or e-mail globaldev@adelphia.net or visit the NBM web and e-commerce site at nbmx.com
The statements in this release regarding future results of operation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the company believes the expectations reflected in such forward-looking statements are based on reliable assumptions, it can give no assurance that its expectations will be obtained. The company disclaims any intent or obligation to update these forward-looking statements. SOURCE National Boston Medical, Inc.
SOURCE National Boston Medical, Inc.
/CONTACT: Joseph Griffin of National Boston Medical, Inc., 561-694-9425,
joseph@nbmedical.com/
/Web site: nbmedical.com
/Web site: nbmx.com
(NBMX)
Headlines Next Story
--------------------------------------------------------------------------------
NBMX %MTC %PER |
